跳至主要内容
临床试验/NCT04257773
NCT04257773已完成不适用

International REACH Forgiveness Intervention

City University of Hong Kong5 个研究点 分布在 4 个国家目标入组 4,598 人开始时间: 2020年2月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
4,598
试验地点
5
主要终点
Depression (BSI)

研究概览

简要总结

Six sites spanning five regions (Hong Kong, Colombia, Indonesia, Ukraine, South Africa) will administer a forgiveness workbook intervention in a randomized design with a stepped, waitlist intervention deployment.

详细描述

Intervention deployment:

ODO1 X O2 O3 (immediate-treatment [IT ] group) ODO1 O2 X O3 (delayed-treatment [DT ] group)

where OD denotes measurement of baseline demographic and personality measures, X denotes deployment of the intervention, and O1, O2, and O3 denote measurements of outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must be able to read and comprehend the materials in the workbook
  • Must be 18 years old or above
  • Have someone in mind they want to forgive

排除标准

  • 未提供

结局指标

主要结局

Depression (BSI)

时间窗: 4 months

Brief Symptom Index, minimum value = 0, maximum value = 4. Higher scores indicates a higher psychological distress.

Forgiveness (TRIM)

时间窗: 4 months

Transgression-Related Interpersonal Motivations, minimum value = 1, maximum value = 5. The higher the score, the more unforgiving the person is.

Anxiety (BSI)

时间窗: 4 months

Brief Symptom Index. minimum value = 0, maximum value = 4. Higher scores indicates a higher psychological distress.

次要结局

  • Decision to Forgive (DTSF)(4 months)
  • Forbearance (FS)(4 months)
  • Trait Forgiveness (TSF)(4 months)
  • Flourishing(4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. HO Man Yee

Assistant Professor

City University of Hong Kong

研究点 (5)

Loading locations...

相似试验

已完成
3 期
A 52-Week, Open-Label, Prospective, Multicenter, International Study of a Transition to the Paliperidone Palmitate 3-Month Formulation In Patients with Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation.split personalitySchizofrenia10037173
NL-OMON43400Janssen-Cilag6
已完成
4 期
A Multi Center, Prospective, Observational, Open-label, Pharmacokinetic Study of Tacrolimus in Heart and Lung Transplantation Patients during the First Days after TransplantatioHeart and lung transplantation100192801003868610038716
NL-OMON39373niversitair Medisch Centrum Utrecht30
已完成
2 期
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS) [DELIVERS Study]
NL-OMON47706Castle Creek Pharmaceuticals, LLC4
已完成
3 期
A MULTI-CENTRE, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, TWO-ARMED, PARALLEL GROUP STUDY TO EVALUATE EFFICACY AND SAFETY OF IV SILDENAFIL IN THE TREATMENT OF NEONATES WITH PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN (PPHN) OR HYPOXIC RESPIRATORY FAILURE AND AT RISK FOR PPHN, WITH A LONG TERM FOLLOW-UP INVESTIGATION OF DEVELOPMENTAL PROGRESS 12 AND 24 MONTHS AFTER COMPLETION OF STUDY TREATMENTAanhoudende pulmonale hypertensie van de pasgeborene (PPHN)10028971PPHN
NL-OMON37174Pfizer5
招募中
3 期
Improving newborn survival in preterm birth
CTRI/2021/03/032429World Health Organization